BRPI0513937A - fragmentos de rnat transferase - Google Patents

fragmentos de rnat transferase

Info

Publication number
BRPI0513937A
BRPI0513937A BRPI0513937-6A BRPI0513937A BRPI0513937A BR PI0513937 A BRPI0513937 A BR PI0513937A BR PI0513937 A BRPI0513937 A BR PI0513937A BR PI0513937 A BRPI0513937 A BR PI0513937A
Authority
BR
Brazil
Prior art keywords
fragments
methods
trna synthetase
angiogenesis
trna
Prior art date
Application number
BRPI0513937-6A
Other languages
English (en)
Inventor
Paul F Glidden
Original Assignee
Angiosyn Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/962,171 external-priority patent/US20060079473A1/en
Priority claimed from US10/961,529 external-priority patent/US20060079441A1/en
Priority claimed from US10/962,375 external-priority patent/US20060078553A1/en
Priority claimed from US10/961,528 external-priority patent/US20060078887A1/en
Priority claimed from US10/962,062 external-priority patent/US20060078556A1/en
Priority claimed from US10/962,217 external-priority patent/US20060079673A1/en
Priority claimed from US10/962,218 external-priority patent/US20060079474A1/en
Priority claimed from US10/962,058 external-priority patent/US20060079472A1/en
Priority claimed from US10/961,486 external-priority patent/US20060078886A1/en
Application filed by Angiosyn Inc filed Critical Angiosyn Inc
Publication of BRPI0513937A publication Critical patent/BRPI0513937A/pt

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

FRAGMENTOS DE RNAt TRANSFERASE. A presente invenção se relaciona com composições e métodos para tratar condições associadas com a angiogênese. Em particular, a presente invenção se relaciona a complexos de unidades múltiplas de fragmentos de RNAt sintetase e usos dos mesmos; diversos complexos de unidades múltiplas incluindo um fragmento de RNAt sintetase; composições e métodos para modular a angiogênese; polipeptídeos codificando fragmentos de RNAt sintetase e usos dos mesmos; anticospos e epítopos específicos para fragmentos de RNAt sintetase; variantes de fragmentos de RNAt sintetase e usos dos mesmos; métodos de tratamento de angiogênese; métodos para selecionar agentes anti-angiogênicos; métodos para modular a angiogênese; conjuntos para modular a angiogênese; e métodos empresariais para modular a angiogênese. Preferivelmente, os fragmentos de RNAt sintetase são fragmentos de RNAt triptofanil sintetase, e mais preferivelmente fragmentos de RNAt sintetase de tripotofanil humana.
BRPI0513937-6A 2004-08-02 2005-07-21 fragmentos de rnat transferase BRPI0513937A (pt)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US59801904P 2004-08-02 2004-08-02
US10/962,171 US20060079473A1 (en) 2004-10-07 2004-10-07 Multi-unit complexes and uses thereof
US10/961,529 US20060079441A1 (en) 2004-10-07 2004-10-07 Methods of modulating angiogenesis
US10/962,375 US20060078553A1 (en) 2004-10-07 2004-10-07 Diverse multi-unit complexes including a tRNA synthetase fragment
US10/961,528 US20060078887A1 (en) 2004-10-07 2004-10-07 Methods for screening for anti-angiogenic agents
US10/962,062 US20060078556A1 (en) 2004-10-07 2004-10-07 Antibodies and epitopes specific to tRNA synthetase fragments
US10/962,217 US20060079673A1 (en) 2004-08-02 2004-10-07 Polynucleotides encoding tRNA synthetase fragments and uses thereof
US10/962,218 US20060079474A1 (en) 2004-10-07 2004-10-07 Analogs of tRNA synthetase fragments and uses thereof
US10/962,058 US20060079472A1 (en) 2004-10-07 2004-10-07 Methods for treating angiogenesis
US10/961,486 US20060078886A1 (en) 2004-10-07 2004-10-07 Business methods for modulating angiogenesis
PCT/IB2005/002180 WO2006016217A1 (en) 2004-08-02 2005-07-21 tRNA SYNTHETASE FRAGMENTS

Publications (1)

Publication Number Publication Date
BRPI0513937A true BRPI0513937A (pt) 2007-10-23

Family

ID=38602996

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513937-6A BRPI0513937A (pt) 2004-08-02 2005-07-21 fragmentos de rnat transferase

Country Status (1)

Country Link
BR (1) BRPI0513937A (pt)

Similar Documents

Publication Publication Date Title
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
PH12017502286A1 (en) Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi)
EA200602241A1 (ru) Замещённые индазолы, композиции, содержащие указанные индазолы, способ их получения и применение
CL2011002756A1 (es) Anticuerpo que se enlaza a la proteina del complemento c3b humana o de cinomolgo; composicion farmaceutica, acido nucleico, vector y celula huesped que comprenden dicho anticuerpo; uso para tratar degeneracion macular relacionada con la edad.
BRPI0813311A2 (pt) Composto, métodos para modulara a atividade de uma proteína quinase e para tratar câncer em um indivíduo, e, composição farmacêutica.
BR112013017080A8 (pt) Anticorpo ou fragmento funcional do mesmo que se liga a forma ativa de calicreína do plasma humano, composiçao farmacêutica e método de detecçao de calicreína do plasma em um paciente
BR112014029099A2 (pt) anticorpos anti-egfr e seu uso para inibir ou atenuar crescimento de tumor, bem como composição farmacêutica que o compreende
MX2007001505A (es) Fragmentos de arnt sintetasa.
EA201290209A1 (ru) Новые модуляторы бензопиран киназы
NO20074446L (no) DR5-antistoffer og anvendelser derav
EA201892184A1 (ru) Оптимизированные моноклональные антитела против ингибитора пути тканевого фактора
AU2013205271B2 (en) Human CGRP receptor binding proteins
JO2576B1 (en) Antibodies
CR11580A (es) Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf
CY1111622T1 (el) Ανθρωποποιημενοι ανταγωνιστες anti-cmet
UA104585C2 (ru) Композиция, содержащая антитело, которое связывается с доменом ii her2, и его кислые варианты
BRPI0907135B8 (pt) uso de um anticorpo antagonista anti-cgrp para a prevenção e/ou tratamento de dor de câncer crônica
NO20084712L (no) Nye farmasoytiske forbindelser
EA201300242A1 (ru) Фармацевтические композиции, содержащие замещенные ациланилиды
BRPI0408247A (pt) usos de antagonistas e agonistas de il-23 e reagentes relacionados
CR10147A (es) "ligandos que tienen especificidad de enlace para vegf y/o egfr y métodos de uso de los mismos"
ATE387435T1 (de) Substituirte benzosulfonamide als potenzierungsmittel von glutamatrezeptoren
CL2007001488A1 (es) Anticuerpo humano o humanizado anti-integrina alfa5beta1; acido nucleico que lo codifica; vector y celula huesped que lo comprenden; procedimiento de produccion; composicion farmaceutica que lo comprende; y su uso para prevenir o tratar trastornos asociados con la integrina.
IL194550A (en) Isolated antibodies or their fragments that bind to human protein tyrosine phosphate in a cell, their pharmaceutical preparations and their use
TR201818814T4 (tr) Dll4 antagonist antikorlarının ve anti-hipertansif ajanların terapötik kombinasyonu ve kullanımı.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2264 DE 27/05/2014.